General Information of the Compound
| Compound ID |
CP0418937
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-[(E)-3-[2,5-bis(trifluoromethyl)phenyl]prop-2-enoyl]oxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H30F6O8
|
||||||||||||||||||
| Molecular Weight |
656.572
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)[C@@H]1C[C@H](OC(=O)\C=C\c2cc(ccc2C(F)(F)F)C(F)(F)F)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)c1ccoc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H30F6O8/c1-29-10-8-20-28(42)46-23(17-9-11-44-15-17)14-30(20,2)26(29)25(40)22(13-21(29)27(41)43-3)45-24(39)7-4-16-12-18(31(33,34)35)5-6-19(16)32(36,37)38/h4-7,9,11-12,15,20-23,26H,8,10,13-14H2,1-3H3/b7-4+/t20-,21-,22-,23-,26-,29-,30-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SUNSCRUZBUVEFH-ULSWFXIYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor